GLOBALSTRAT (08007) intends to offer a discount of approximately 16.98% to sell up to 37.7196 million shares. The net proceeds are expected to be approximately 78.8 million Hong Kong dollars.
Global Strategic Group (08007) announces that on April 2, 2026 (after trading hours of the Stock Exchange), the Company has entered into a placement agreement with the placing agent, whereby the Company conditionally agrees to place up to 37.7196 million shares to not less than 6 placees who are independent third parties or their ultimate beneficial owners at a placing price of HK$0.22 per placing share. The placing shares will be issued and allotted based on the general mandate received by the directors at the Annual General Meeting of the shareholders. The issuance and allotment of the placing shares do not require approval from shareholders.
GLOBALSTRAT (08007) announced that on April 2, 2026 (after trading hours on the Stock Exchange), the Company entered into a placement agreement with the placing agent. Under this agreement, the Company conditionally agreed to place up to 37.7196 million shares to not less than 6 subscribers who are independent third parties or their ultimate beneficial owners at a price of HK$0.22 per share. The shares will be issued and allotted based on the general mandate granted to the directors at the annual general meeting and does not require approval from shareholders.
Assuming there are no changes in the Company's issued share capital from the date of the announcement until the completion of the placement, the placement shares represent approximately (i) 20% of the existing issued shares on the announcement date; and (ii) around 16.67% of the enlarged issued share capital after full issuance of the placement shares. The placement price of HK$0.22 per share represents a discount of approximately 16.98% to the closing market price of HK$0.265 per share on the Stock Exchange on April 2, 2026.
If all placement shares are successfully placed by the placing agent, the estimated total gross proceeds from the placement is around HK$83 million, and after deducting placement commissions, professional fees, and all related expenses that the Company may bear, the estimated net proceeds from the placement is approximately HK$78.8 million. The Company intends to use the net proceeds as follows: approximately HK$43 million (around 54.58% of the net proceeds) for the redemption of the Company's bonds; around HK$10 million (approximately 12.69% of the net proceeds) for the payment of professional fees of the Group; and approximately HK$25.8 million (around 32.73% of the net proceeds) as general working capital for the Group.
Related Articles

The United States plans to implement a new tariff policy on the pharmaceutical industry, with rates as high as 100%.

US Stock Market Move | The optical communication sector surged, Applied Optoelectronics (AAOI.US) rose nearly 18%.

US Stock Market Move | General Motors Company (GM.US) fell by 3% in the first quarter, with sales in the American market dropping by approximately 10% year-on-year.
The United States plans to implement a new tariff policy on the pharmaceutical industry, with rates as high as 100%.

US Stock Market Move | The optical communication sector surged, Applied Optoelectronics (AAOI.US) rose nearly 18%.

US Stock Market Move | General Motors Company (GM.US) fell by 3% in the first quarter, with sales in the American market dropping by approximately 10% year-on-year.

RECOMMEND

Hong Kong Stocks Surge! Buying Opportunity Or Wait And See? Analysts Provide Comprehensive Interpretation
02/04/2026

Narrative Drives Everything As China’s AI Newcomers Enter An Era Of Extreme Volatility, Retail Investors Flood In
02/04/2026

Fund Cohort Stocks Rally As Institutional Confidence In Hong Kong Equities Shows Signs Of Repair
02/04/2026


